Pegvaliase was approved by FDA in 2018 for
Pegvaliase is a drug approved for the treatment of phenylketonuria. Chemically, it is a pegylated derivative of the enzyme phenylalanine ammonia-lyase that metabolizes phenylalanine to reduce its blood levels.
Phenylketonuria
Pancreatic tumours
Crohn's disease
Glycogen storage disorders
All India exam